Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds

Cancer. 1996 Nov 1;78(9):1996-2003.

Abstract

Background: Multiple endocrine neoplasia type 2 (MEN 2) is a group of related autosomal dominant cancer syndromes caused by mutations in the RET protooncogene. A subset of familial Hirschsprung's disease, aganglionic megacolon, is also caused by mutations in this gene.

Methods: The authors performed mutation analysis of exons 10, 11, 13, and 16 of the RET gene is six established MTN 2 kindreds and in six patients with apparent sporadic disease, in order to correlate their genotypes and phenotypes.

Results: One of these kindred's carried both Hirschsprung's disease and MEN 2A in conjunction with a cysteine-to-arginine substitution of codon 620 of the RET gene. One patient with apparently sporadic disease was found to have a germline M918T mutation. Patients with confirmed familial disease all carried pathologic germline mutations of RET.

Conclusions: Several lines of evidence support a gain of function mechanism for tumorigenesis in the MEN 2 syndromes but a loss of function mechanism for aganglionosis in Hirschsprung's disease. The authors propose that a multihit mechanism can reconcile the apparent paradox of a single mutation that gives rise to both gain and loss of function disorders in a single patient.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Child
  • Family*
  • Female
  • Hirschsprung Disease / genetics
  • Humans
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 2a / genetics*
  • Mutation / genetics*
  • Oncogene Proteins / genetics
  • Pedigree
  • Proto-Oncogene Proteins c-ret
  • Proto-Oncogenes / genetics*
  • Receptor Protein-Tyrosine Kinases / genetics

Substances

  • Oncogene Proteins
  • Proto-Oncogene Proteins c-ret
  • RET protein, human
  • Receptor Protein-Tyrosine Kinases